Alphabet is launching a company that uses AI for drug discovery

msingleton 180612 2663 0002.0

Photo by Micah Singleton / The Verge

A new Alphabet company will use artificial intelligence methods for drug discovery, Google’s parent company announced Thursday. It’ll build off of the work done by DeepMind, another Alphabet subsidiary that has done groundbreaking work using AI to predict the structure of proteins.

The new company, called Isomorphic Laboratories, will leverage that success to build tools that can help identify new pharmaceuticals. DeepMind CEO Demis Hassabis will also serve as the CEO for Isomorphic, but the two companies will stay separate and collaborate occasionally, a spokesperson said.

For years, experts have pointed to AI as a way to make it faster and cheaper to find new medications to treat various conditions. AI could help scan through…

Continue reading…

Leave a Reply

Your email address will not be published.